These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1499 related articles for article (PubMed ID: 33763077)

  • 41. BCG vaccination provides protection against IAV but not SARS-CoV-2.
    Kaufmann E; Khan N; Tran KA; Ulndreaj A; Pernet E; Fontes G; Lupien A; Desmeules P; McIntosh F; Abow A; Moorlag SJCFM; Debisarun P; Mossman K; Banerjee A; Karo-Atar D; Sadeghi M; Mubareka S; Vinh DC; King IL; Robbins CS; Behr MA; Netea MG; Joubert P; Divangahi M
    Cell Rep; 2022 Mar; 38(10):110502. PubMed ID: 35235831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development.
    Pasco ST; Anguita J
    Cells; 2020 Sep; 9(9):. PubMed ID: 32948003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?
    Sharma AR; Batra G; Kumar M; Mishra A; Singla R; Singh A; Singh RS; Medhi B
    Allergol Immunopathol (Madr); 2020; 48(5):507-517. PubMed ID: 32653224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fiction and Facts about BCG Imparting Trained Immunity against COVID-19.
    Kaur G; Singh S; Nanda S; Zafar MA; Malik JA; Arshi MU; Lamba T; Agrewala JN
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic].
    Kalyuzhin OV; Andronova TM; Karaulov AV
    Ter Arkh; 2020 Dec; 92(12):195-200. PubMed ID: 33720594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is There a Rationale for Using
    Maheshwari N; Jain A
    Viral Immunol; 2021 Jun; 34(5):300-306. PubMed ID: 32857679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection.
    Chowdhury UN; Faruqe MO; Mehedy M; Ahmad S; Islam MB; Shoombuatong W; Azad AKM; Moni MA
    Comput Biol Med; 2021 Nov; 138():104891. PubMed ID: 34624759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BCG immunomodulation: From the 'hygiene hypothesis' to COVID-19.
    Moulson AJ; Av-Gay Y
    Immunobiology; 2021 Jan; 226(1):152052. PubMed ID: 33418320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
    Wang Y; Ge F; Wang J; Li H; Zheng B; Li W; Chen S; Zheng X; Deng Y; Wang Y; Zeng R
    J Virol; 2023 Mar; 97(3):e0176422. PubMed ID: 36779760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19.
    Morrison AL; Sharpe S; White AD; Bodman-Smith M
    Front Immunol; 2021; 12():743924. PubMed ID: 34567010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
    Tomita Y; Sato R; Ikeda T; Sakagami T
    Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2.
    Ramos-Martinez E; Falfán-Valencia R; Pérez-Rubio G; Andrade WA; Rojas-Serrano J; Ambrocio-Ortiz E; Galicia-Álvarez DS; Bárcenas-Montiel I; Velasco-Medina A; Velázquez-Sámano G
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.
    Ten Doesschate T; Moorlag SJCFM; van der Vaart TW; Taks E; Debisarun P; Ten Oever J; Bleeker-Rovers CP; Verhagen PB; Lalmohamed A; Ter Heine R; van Crevel R; van de Wijgert J; Janssen AB; Bonten MJ; van Werkhoven CH; Netea MG;
    Trials; 2020 Jun; 21(1):481. PubMed ID: 32503602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "Trained immunity" from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes.
    Singh S; Maurya RP; Singh RK
    PLoS Pathog; 2020 Oct; 16(10):e1008969. PubMed ID: 33119725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses.
    DiNardo AR; Arditi M; Kamat AM; Koster KJ; Carrero S; Nishiguchi T; Lebedev M; Benjamin AB; Avalos P; Lozano M; Moule MG; McCune B; Herron B; Ladki M; Sheikh D; Spears M; Herrejon IA; Dodge C; Kumar S; Hutchison RW; Ofili TU; Opperman LA; Bernard JA; Lerner SP; Udeani G; Neal G; Netea MG; Cirillo JD
    Trials; 2023 Oct; 24(1):636. PubMed ID: 37794431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration.
    Ayoub BM; Ramadan E; Ashoush N; Tadros MM; Hendy MS; Elmazar MM; Mousa SA
    Pharmazie; 2020 Aug; 75(8):375-380. PubMed ID: 32758336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BCG Vaccine, A Ray of Hope in Treating Severe Acute Respiratory Syndrome (SARS).
    Banerjee AB; Singh TG; Prashar A
    Infect Disord Drug Targets; 2021; 21(5):e270421186935. PubMed ID: 33069201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacille Calmette-Guérin Vaccination in Infancy Does Not Protect Against Coronavirus Disease 2019 (COVID-19): Evidence From a Natural Experiment in Sweden.
    de Chaisemartin C; de Chaisemartin L
    Clin Infect Dis; 2021 May; 72(10):e501-e505. PubMed ID: 32829400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.